Cellular and Molecular Biology
Scientific program
February 26, 2025   09:00 AM GMT

International webinar onCellular and Molecular Biology

Early Bird Registration End Date: Feb 07, 2025
Abstract Submission Opens: Dec 02, 2024

Latest News

Intra-Cellular Therapies acquisition will expand J&J’s presence in neurology space, says GlobalData

2025-01-18 - 2025-01

Johnson & Johnson (J&J) recently announced the acquisition of Intra-Cellular Therapies, a biopharmaceutical company specialising in the development of treatments targeting complex psychiatric and neurological disorders. The deal is the biggest biotech M&A transaction since 2023. As part of the acquisition, J&J will obtain Intra-Cellular’s extensive neurology portfolio, which will allow them to grow its market share in major indications such as schizophrenia, agitation and psychosis in Alzheimer’s Disease, Parkinson’s disease, and opioid use disorder, says GlobalData.


Subscribe Now